Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 04/04/14 | S-3 | Registration statement for specified transactions by certain issuers |
|
41 | |
| 04/04/14 | 8-K | Current report filing |
|
34 | |
| 04/01/14 | 8-K | Current report filing |
|
16 | |
| 03/31/14 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
   |
157 |
| 02/10/14 | 3 | Initial statement of beneficial ownership of securities |
|
2 | |
| 02/10/14 | SC 13G | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
9 | |
| 02/06/14 | 8-K | Current report filing |
|
6 | |
| 02/04/14 | S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans |
|
12 | |
| 02/04/14 | 8-K | Current report filing |
|
29 | |
| 01/23/14 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
31 |
